Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,935 | -21,123 | -15,630 | -9,844 | -5,064 |
| Depreciation Amortization | 15 | 70 | 56 | 40 | 24 |
| Accounts payable and accrued liabilities | -32 | 424 | 490 | 307 | -31 |
| Other Working Capital | -250 | 135 | -104 | -394 | -321 |
| Other Operating Activity | 431 | 1,366 | 987 | 737 | 598 |
| Operating Cash Flow | $-6,771 | $-19,128 | $-14,201 | $-9,154 | $-4,794 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 7,174 | 7,174 | 7,174 | 4,694 |
| PPE Investments | -2 | -5 | -2 | -2 | N/A |
| Investing Cash Flow | $-2 | $7,169 | $7,172 | $7,172 | $4,694 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 532 | 18,519 | 17,401 | 17,400 | 1,102 |
| Financing Cash Flow | $532 | $18,519 | $17,401 | $17,400 | $1,102 |
| Exchange Rate Effect | -2 | -5 | -3 | -4 | N/A |
| Beginning Cash Position | 25,585 | 19,030 | 19,030 | 19,030 | 19,030 |
| End Cash Position | 19,342 | 25,585 | 29,399 | 34,444 | 20,032 |
| Net Cash Flow | $-6,243 | $6,555 | $10,369 | $15,414 | $1,002 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,771 | -19,128 | -14,201 | -9,154 | -4,794 |
| Capital Expenditure | -2 | -5 | -2 | -2 | N/A |
| Free Cash Flow | -6,773 | -19,133 | -14,203 | -9,156 | -4,794 |